Covaxin recommended by expert panel for children from 2 to 18 years

New Delhi, Oct 12: Subject Expert Committee (SEC) has given a recommendation to DCGI (Drugs Controller General of India) for the use of BharatBiotech’s Covaxin for 2-18 year olds, reports ANI quoting sources. Covaxin, indigenously developed by Bharat Biotech

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News